Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

Study examines drug delivery systems activated by light

A study published in a special issue of Photochemistry and Photobiology examines the emerging practice of drug delivery systems which use the application of light to activate medications in the body.

30 Mar 2009

Angiogenesis inhibitor improves glioblastoma survival by reducing edema

The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.

30 Mar 2009

DSM obtains exclusive world-wide license for innovative drug delivery technology

Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.

12 Mar 2009

Researchers develop 'wireless' activation of brain circuits

Traditionally, stimulating nerves or brain tissue involves cumbersome wiring and a sharp metal electrode.

23 Feb 2009

Good bacteria may provide effective vehicle for an oral vaccine against anthrax

Researchers at North Carolina State University have discovered that the good bacteria found in dairy products and linked to positive health benefits in the human body might also be an effective vehicle for an oral vaccine that can provide immunity to anthrax exposure.

17 Feb 2009

Endo Pharmaceuticals announces research collaborations on novel pain treatments and potential cancer treatments

Endo Pharmaceuticals has announced that it has signed two research collaboration agreements to develop novel treatments for pain and to discover potential treatments for cancer.

10 Feb 2009

Remote Intelligent Drug Delivery System (RIDDS) may soon be a reality

Electronic implants that dispense medicines automatically or via a wireless medical network are on the horizon. Australian and US researchers warn of the security risks in a forthcoming issue of the International Journal of Biomedical Engineering and Technology .

8 Feb 2009

Advances in vivo biological imaging

The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen the chemist Wei Sun (26) as the recipient of its Best Paper Award 2008.

8 Feb 2009

Quantum dot hazards

Quantum dots have the potential to bring many good things into the world: efficient solar power, targeted gene and drug delivery, solid-state lighting and advances in biomedical imaging among them.

2 Feb 2009

Genetic variations associated with treatment response for acute lymphoblastic leukemia

Children with acute lymphoblastic leukemia with certain genetic variations can have a different response to anti-cancer treatment than other patients, according to a study in the January 28 issue of JAMA, the Journal of the American Medical Association.

29 Jan 2009

Leconotide, an investigative calcium channel blocker, shows potential as pain treatment

Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.

29 Jan 2009

Polymer nanoparticle for oral anticancer drug delivery

One of the problems that cancer patients face is that many of the most potent anticancer therapies can be administered only by injection, which means that cancer patients must travel to receive their medication. But thanks to a new type of nanoparticle developed by researchers at the Johns Hopkins University School of Medicine, future cancer patients may be able to receive their medication in pill form.

18 Jan 2009

Tiny particle syringe for drug delivery

A tiny particle syringe composed of polymer layers and nanoparticles may provide drug delivery that targets diseased cells without harming the rest of the body, according to a team of chemical engineers.

12 Jan 2009

Researchers learn to synthesize and control the formation of nanobristles

From the structure of DNA to nautical rope to distant spiral galaxies, helical forms are as abundant as they are useful in nature and manufacturing alike.

9 Jan 2009

Endo Pharmaceuticals to acquire Indevus Pharmaceuticals

Endo Pharmaceuticals (NASDAQ:ENDP) and Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) announced today that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash, and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones.

5 Jan 2009